These compounds may interact with:
Cannabinoid receptor 2
Potentially involved in: ovarian hyperstimulation syndrome; glycerol kinase deficiency; pain agnosia; chromosome xp21 deletion syndrome; alcoholic intoxication, chronic; atherosclerosis; bipolar disorder; mental depression; depressive disorder; hyperalgesia; immune system diseases; leukemia, myelocytic, acute; liver cirrhosis; marijuana abuse; pancreatic neoplasm; pancreatitis; psychotic disorders; schizophrenia; alcohol abuse; mammary neoplasms
Disease data sourced from Pharos.